Assignee
SATIOGEN PHARMACEUTICALS INC
US·6 granted patents·3 pending applications·19 citations·filing 2006–2022
Top patents by PatentIndex Score
9 records- 0188US9345715B2Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereofSATIOGEN PHARMACEUTICALS INC·Filed 2012·Granted May 24, 2016·10 cites·11 claims
- 0286US11260053B2Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditionsSATIOGEN PHARMACEUTICALS INC·Filed 2019·Granted Mar 1, 2022·1 cites·21 claims
- 0380US10555950B2Bile acid recycling inhibitors for treatment of obesity and diabetesSATIOGEN PHARMACEUTICALS INC·Filed 2016·Granted Feb 11, 2020·2 cites·6 claims
- 0480US10251880B2Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditionsSATIOGEN PHARMACEUTICALS INC·Filed 2014·Granted Apr 9, 2019·3 cites·12 claims
- 0577US2022362238A1Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditionsSATIOGEN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0661US8366650B2Biliary/pancreatic shunt device and method for treatment of metabolic and other diseasesSATIOGEN PHARMACEUTICALS INC·Filed 2006·Granted Feb 5, 2013·3 cites·30 claims
- 0754US10028952B2Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereofSATIOGEN PHARMACEUTICALS INC·Filed 2016·Granted Jul 24, 2018·0 cites·19 claims
- 0842US2013090590A1Methods and Apparatus for Treating Obesity and DiabetesSATIOGEN PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 0937US2011152204A1Treatment of Obesity or Diabetes with Bile Acid SequestrantsSATIOGEN PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →